Ophthalmic Stem Cell Therapy - An Overview

What Is Stem Cell Therapy?

Stem cell therapy is a groundbreaking medical treatment that regenerates or repairs damaged cells or tissues using stem cells, which aids in treating or preventing a disease or condition. Stem cell therapy has shown promising results in treating a variety of conditions, from Parkinson's disease, Crohn's disease, Alzheimer's disease, multiple sclerosis, and heart conditions like myocardial infarction. Mesenchymal stem cells (MSCs) are adult stem cells commonly used in many stem cell therapies because of their versatility and fewer ethical concerns than fetal stem cells or embryonic cells. Researchers are investigating whether stem cell therapy can treat various kinds of eye diseases, including age-related macular degeneration (AMD), glaucoma, inherited retinal diseases (IRDs), and corneal diseases.

What Is a Stem Cell?

A stem cell is a unique sort of cell, it can self-renew and differentiate into several specialized cell types, like brain, blood, muscle, or retinal cells. Stem cells are seen in most of the tissues in the body. They are required for the maintenance and repair of tissue after any injury. While other adult cells are unable to carry out this function, stem cells, which are present in a variety of tissues, are crucial to the body's processes of regeneration and repair. For instance, a liver cell can only create new liver ones, and a skin cell can only create new skin cells. Furthermore, certain nerve cells, such as retinal cells, are nonproliferative, meaning that they cannot be replaced in the event of damage. One disadvantage of stem cells, though, is that immune reactions may impact them and cause cell damage or death.

What Are Ophthalmic Stem Cells?

Ophthalmic stem cell therapy employs stem cells to either replace or repair damaged cells within the eye. Researchers are investigating human stem cells sourced from various origins for transplantation therapies targeting eye diseases. These therapies aim to directly repair damaged tissue or fulfill crucial tissue functions, as well as produce necessary trophic and growth factors to retard disease progression.

Several types of stem cells have shown promising results in treating eye disorders:

1)Pluripotent Stem Cells: These cells have the ability to differentiate into any kind of somatic tissue (cells in the body other than sperm and egg cells), including all ocular cells. Both induced pluripotent stem cells (iPSCs) and pluripotent human embryonic stem cells (hESCs) are types of pluripotent cells that support eye replacement therapies by virtually endlessly generating eye cells. The primary benefit of utilizing iPSCs is the elimination of the need for immunoprotective protocols following transplantation because these cells are derived from the patient. Pluripotent stem cells have a number of drawbacks, one of which is that they can lead to tumor formation or unintended cell proliferation, particularly in iPSCs. New methods, however, lessen the harm posed by tumors by assisting in the removal of external reprogramming agents.

2) Neural Stem Cells (NSCs): Human neural stem cells (NSCs) are derived from donated fetal forebrain tissue. They are multipotent cells that can endlessly divide and self-renew, giving rise to new cells that eventually transform into neurons, astrocytes, and oligodendrocytes. NSCs have the capability to generate neurons and glia, though they are unable to produce retinal pigment epithelium or neural retina. Despite this limitation, NSCs demonstrate effectiveness in generating cells that can replicate several crucial functions of these tissues and also produce specialized trophic factors that can be beneficial.

3) Mesenchymal Stem Cells (MSCs): Mesenchymal stem cells have the ability to self-renew and also undergo differentiation. They are developed from various sources like bone marrow or adipose tissue and possess anti-inflammatory and immunomodulatory properties. These attributes position MSCs as potential candidates for the treatment of eye diseases characterized by inflammation.

4) RPE Stem Cells: RPE (retinal pigment epithelium) is a tightly arranged monolayer of pigmented cells that has a vital role in photoreceptor maintenance and visual function. In tissue culture, adult human RPE stem cells permit RPE cell degeneration, and they are being researched for their potential to generate other types of eye cells.

5) Embryonic Stem Cells (ESCs): These stem cells are developed from embryos. These cells can differentiate into any cell type in the body, including those found in the eye.

What Are the Applications of Ophthalmic Stem Cells?

Ophthalmic stem cells are used in a wide range of diseases related to the eyes, including:

• Glaucoma - Glaucoma, an irreversible condition, is characterized by progressive damage to the optic nerve, resulting in a reduction in the number of retinal ganglion cells (RGCs) and eventual vision impairment. While medical treatment and surgical interventions can slow down the progression of the disease, they cannot completely halt the degeneration of these cells. Stem cells offer the potential to safeguard RGCs, stimulate optic nerve regeneration, and enhance their survival.

• Age-related Macular Degeneration (AMD) - Damage to the macula, a small but crucial part of the retina responsible for central vision, can result in age-related macular degeneration, which can cause progressive vision loss. MSCs were able to stimulate the differentiation of photoreceptor cells in a research investigation. They can also repair the macula and prevent the damage of retinal cells and photoreceptors.

• Diabetic Retinopathy (DR) - Elevated levels of blood sugar can damage the blood vessels of the eyes. Inflammation, neuronal cell death, and retinal blood vessel damage can all result from diabetic retinopathy. Preclinical and clinical research on stem cell therapy yields encouraging findings, markedly enhancing visual parameters.

• Retinal Degenerative Diseases - Inherited retinal degenerative conditions like Stargardt disease and retinitis pigmentosa result in the progressive loss of photoreceptor cells, causing vision impairment. Stem cell therapy plays a crucial role in replacing these cells, thereby preserving photoreceptors and improving visual function.

• Corneal Disorders - Conditions affecting the cornea, such as epithelial defects or corneal opacity, can cause partial or complete vision loss. Stem cell transplantation, particularly utilizing limbal stem cells, helps restore corneal clarity and maintain the health of the ocular surface.

What Are the Complications of Ophthalmic Stem Cell Therapy?

• Immune Rejection - There is always a risk of immune-mediated rejection reactions following transplantation, even when induced pluripotent stem cells (iPSCs) are used to minimize immune rejection. In these cases, the immune system might recognize the transplanted cells as foreign substances and increase an immunological response, which results in graft rejection.

• Infection - Any surgical procedure carries a risk of infection. Infections can occur anytime during the procedure, leading to scarring, inflammation, and vision loss.

• Tumorigenesis - Stem cell therapy has the risk of tumorigenesis, meaning the formation of tumors, particularly with the use of pluripotent stem cells.

• Graft Failure - Graft failure can occur due to various factors, such as inadequate vascularization, poor integration of transplanted cells, or immune-mediated rejection.

• Secondary Complications - Ophthalmic stem cell therapy can lead to secondary complications such as glaucoma, cataract formation, or retinal detachment. These complications can occur as a result of the surgical procedure or due to the presence of foreign material in the eye.

Conclusion

Ophthalmic stem cell therapy is a transformative approach to treating different eye disorders. This therapy can restore vision and improve the quality of life of the affected individuals. With the help of stem cells, the damaged eye cells can be replaced to regenerate new cells, aiding in vision enhancement. It also has drawbacks like rejection, graft failure, and infections. However, studies are being conducted to provide better outcomes in ophthalmic stem cell therapy.